Pancreatitis link to diabetes drugs grows

Evidence is mounting that the newer generation diabetes drugs sitagliptin (Januvia) and exenatide (Byetta) can increase the risk of acute pancreatitis.

The latest study, published Tuesday in JAMA Internal Medicine (online), found diabetes patients currently taking either medication were about twice as likely to be hospitalised for pancreatitis as those who had never taken either.

The same held true for patients who had ever taken one